JDOC stock forecast, quote, news & analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Abbott Laboratories (NYSE:ABT), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Bristol-Myers Squibb Co (NYSE:BMY).

The investment seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.

The average market capitalization across the JPMorgan Healthcare Leaders ETF ETF is 91.76B. The market cap for tickers in the group ranges from 3.51M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is NOVN at 3.51M.

The average weekly price growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was -6%. For the same ETF, the average monthly price growth was -9%, and the average quarterly price growth was -5%. NTRA experienced the highest price growth at 9%, while HALO experienced the biggest fall at -25%.

The average weekly volume growth across all stocks in the JPMorgan Healthcare Leaders ETF ETF was 35%. For the same stocks of the ETF, the average monthly volume growth was 100% and the average quarterly volume growth was 99%